Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2017, Vol. 22 ›› Issue (7): 738-742.

Previous Articles     Next Articles

Curcumin alleviate intrapulmonary inflammation in rat experimental hepatopulmonary syndrome

LI Xujiong 1, LIU An 2, CHEN Yunxia 3, LI Shufen 1   

  1. 1 Physiology Department of Changzhi Medical College, Changzhi 046000, Shanxi, China; 2 Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; 3 Microbiology Department of Changzhi Medica l College, Changzhi 046000, Shanxi, China
  • Received:2016-08-03 Revised:2016-11-07 Online:2017-07-26 Published:2017-07-19

Abstract:

AIM: To evaluate the protective effect of curcumin in an experimental model of hepatopulmonary syndrome (HPS)  induced by bile duct ligation in rats.  METHODS: One week after surgery, curcumin (50 mg·kg-1·d-1) was administered intragastrically for two weeks. Arterial blood gas analysis was performed. Plasma TNF-α and ALT level was measured. Pathological change in rat lung tissue and liver tissue were observed through HE staining. CD68, TNF-α and NF-κB P-65 were detected by immunofluorescence, and IκBα/p-IκBα was assessed by Western blotting. RESULTS: Curcumin alleviated lung tissue and pulmonary intravascular monocyte accumulation and significantly decreased AaPO. Also, pulmonary TNF-α level and lung tissue NF-κB activity were reduced. CONCLUSION: Curcumin can protect HPS rat from pulmonary inflammation injury. The mechanism may be related with anti-inflammation by inhibition of TNF-α/NF-κB.

Key words: hepatopulmonary syndrome, curcumin, TNF-α, NF-κB

CLC Number: